Hosted on MSN

Sana stock rallies 280% on pancreatic cell transplant study

Shares of Sana Biotechnology (NASDAQ:SANA) rallied 270% post-market on positive results from a study of the transplantation of its allogeneic primary islet cell therapy UP421 into a patient with type ...
Seeking Alpha

Sana Biotechnology: Scope Goes Beyond HIP-Modified Pancreatic Islet Cells For T1D

Sana Biotechnology, Inc. remains a Strong Buy, driven by progress in HIP-modified cell therapies for Type 1 Diabetes and B-cell-mediated disorders. Sana Biotechnology's HIP-modified islet cell therapy ...
Nasdaq

Sana Biotechnology Reports Promising Six-Month Results from First-in-Human Study on Hypoimmune-Modified Pancreatic Islet Cell Transplant for Type 1 Diabetes

Sana Biotechnology reports six-month results from a first-in-human study demonstrating safe pancreatic islet cell transplantation for type 1 diabetes without immunosuppression. Sana Biotechnology ...
Seeking Alpha

Sana Biotechnology A Buy On Low Price And First IND

Sana had its first clinical trial cleared for initiation by the FDA in January. The current stock price is way below the 2021 IPO price. Restructuring should help, but positive data is crucial going ...
Forbes

‘My Life With The Walter Boys’ Season 2 Ending Explained—Who Does Jackie Choose?

Warning: Spoilers ahead for My Life with the Walter Boys Season 2. After a two-and-a-half-year wait, My Life With the Walter Boys is back for a second season. Does Jackie finally choose between the ...